Imeik Technology Development Co (300896) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Q1 2025 revenue was RMB 663.47 million, down 17.9% year-over-year from RMB 808.09 million.
Net profit attributable to shareholders was RMB 443.74 million, a 15.87% decrease year-over-year.
Adjusted net profit (excluding non-recurring items) was RMB 401.53 million, down 24.02% year-over-year.
Operating cash flow was RMB 332.90 million, a 37.99% decline year-over-year.
The report was not audited.
Financial highlights
Basic and diluted EPS were both RMB 1.47, down from RMB 1.75 in Q1 2024.
Gross margin remained stable; operating costs and expenses were largely in line with the prior year.
Non-recurring gains totaled RMB 42.21 million, mainly from government subsidies and investment gains.
Total assets at quarter-end were RMB 8.72 billion, up 4.5% from year-end 2024.
Shareholders' equity was RMB 8.24 billion, up 5.68% from year-end 2024.
Key financial ratios and metrics
Weighted average ROE was 5.53%, down 2.44 percentage points year-over-year.
Net profit margin declined in line with revenue and profit decreases.
Cash and cash equivalents increased to RMB 3.55 billion, up 134.1% from year-end 2024.
Latest events from Imeik Technology Development Co
- Revenue and profit fell, but global expansion and new products support long-term growth.300896
Q4 202520 Mar 2026 - Revenue and net profit rose over 5% year-over-year, with high margins and strong R&D investment.300896
Q4 202422 Dec 2025 - Revenue and profit declined significantly, impacted by costs and acquisition-related changes.300896
Q3 202522 Dec 2025 - Revenue and profit fell, but global expansion and high margins support long-term growth.300896
Q2 202519 Aug 2025 - Revenue and net profit rose year-over-year, while EPS declined due to share capital expansion.300896
Q3 202413 Jun 2025 - Revenue and net profit grew over 13% and 16% year-over-year, driven by strong core product sales.300896
Q2 202413 Jun 2025